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ABSTRACT cAMP and cGMP differentially bind to and regulate a variety of proteins, including cyclic nucleotide-gated (CNG)
channels and hyperpolarization-activated cyclic nucleotide-regulated (HCN) channels. Previous site-directed mutagenesis
studies have isolated two conserved residues that are critical for enabling certain channels to selectively bind cGMP relative to
cAMP. However, no deﬁnitive mechanism has been identiﬁed that explains the preferential activation of other channels by cAMP.
Here we apply computational binding free energy methods, including thermodynamic integration, linear interaction energy, and
continuum electrostatic calculations, to gain insights into the mechanisms of cyclic nucleotide selectivity. Consistent with ex-
perimental observations, computational results for the cAMP-selective HCN channels show that the binding free energy of cAMP is
lower (more favorable) than that of cGMP. Surprisingly, cAMP selectivity is not due to its preferential contacts with protein, but rather
reﬂects the greater hydration energy of cGMP relative to cAMP, resulting in a greater energetic cost for cGMP binding.
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A large family of cyclic nucleotide (cNMP) regulated pro-
teins, ranging from protein kinases to ion channels, contain a
conserved cyclic nucleotide binding domain (CNBD). The
CNBD contains a fold consisting of a short a-helix (the
A-helix), followed by an eight-strandedb-roll, a short B-helix,
and a long C-helix. The CNBD-containing proteins differ in
their absolute affinity and relative selectivity for cAMPversus
cGMP. Previous studies have identified two conserved
residues within the CNBD that contribute to the ability of
some classes of CNBDs to select for GMP over cAMP. Thus,
a threonine in the b-roll of cGMP-dependent protein kinases
and cNMP-regulated ion channels was first shown to
contribute to cGMP selectivity; mutation of this threonine
to alanine, the residue found in cAMP-dependent protein
kinases, decreases cGMP selectivity (1). In a recent study
usingmolecular dynamics simulations, we confirmed that this
threonine makes three hydrogen bonds with cGMP versus
twowith cAMP, explaining its role in cNMP selectivity (2,3).
However, the threonine residue does not fully define the
ligand selectivity of aCNBD since this residue is conserved in
both cAMP-selective and cGMP-selective cyclic nucleotide-
regulated channels. In theCNGchannel family, an aspartic acid
residue in the C-helix has been shown to be critical for cGMP
selectivity (4). Channels that are selective for cAMP contain
a neutral amino acid at this position; mutation of this residue
to aspartate is sufficient to confer cGMP selectivity (2,5).
Thus, two key residues make a positive contribution to the
preferential stabilization of cGMP relative to cAMP in certain
CNBDs.What is the mechanism that enables other CNBDs to
preferentially bind cAMP over cGMP?Which residues make
specific contributions that stabilize cAMP and what is the
atomic basis for such interactions? Despite extensive muta-
genesis studies, no specific interactions have been identified
that can explain cAMP selectivity. We have focused our
attention on the HCN channels, whose opening in response to
membrane hyperpolarization is facilitated by the binding of
cAMP or cGMP. Although both cAMP and cGMP enhance
gating with roughly similar efficacy, as measured by the
maximal voltage shift at saturating ligand concentrations
(DVmax), the channels have a 60-fold higher sensitivity to
cAMP relative to cGMP, as measured by the concentration
that produces a half-maximal voltage shift (K1/2). We found
that cAMP selectivity could be compromised bymutating one
of several residues in the C-terminus of C-helix, including
R632, R635, I636, and K638. However, despite the existence
of x-ray crystal structures for the cAMP and cGMP-bound
CNBDs of the HCN channels, it is not clear how these
residues generate cAMP selectivity. In addition, theoretical
calculations indicate that cGMP has an even stronger
interaction with the HCN2 CNBD than does cAMP.
Here we address the issue of ligand selectivity by exam-
ining binding free energies using both experimental and
computational approaches. We first determined experimental
free energies using electrophysiological patch-clamp record-
ings to measure the effects of cAMP and cGMP on the gating
of HCN2 channels expressed in Xenopus oocytes. These func-
tional measurements yield values for DVmax, K1/2, and the
maximal increase in channel opening probability at extreme
hyperpolarizations. We then used these experimental values
to extract free energies of ligand binding to the closed (KC) or
open (KO) states of the channel based on a cyclic allosteric
model (see Supplementary Material, Data S1) (2). This anal-
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ysis yields a free energy difference between cAMP and cGMP
binding of ;10 kJ/mol—that is, the channel is cAMP-
selective (Table 1).
What is the mechanism for this selectivity for cAMP
relative to cGMP? To obtain a more comprehensive under-
standing of the ligand selectivity of HCN2, we applied com-
putational approaches based on the x-ray crystal structures of
the cAMP-bound and cGMP-bound CNBD of HCN2 to esti-
mate the theoretical binding free energy of cAMP and cGMP.
In this study, we mainly relied on the MD-based methods,
partially because MD simulations sample the distribution of
two natural occurring stereochemical conformations for
cAMP and cGMP, syn- and anti-, as defined by the dihedral
angle between the purine ring and sugar base. Our MD
simulations showed that cAMP free in water has no significant
preference for its two conformations. However, free cGMP
preferentially adopts the syn conformation (90%). Both results
are in good agreement with previous NMR studies (6).
First, we used the thermodynamic integration (TI) method
(slow-growthmethod) to estimate the binding free energies of
cAMP and cGMP. In this double-decoupling approach,
binding free energy is the difference between two ligand de-
coupling processes: 1), decoupling the ligand bound to pro-
tein; and 2), decoupling the free ligand in water from its
environment. In a stepwise manner, we first turned off the
electrostatic potential energy between ligand and protein (and
also surrounding water), through a series of parallel simula-
tions in which the coupling parameter l-values were reduced
stepwise from 1 to 0 (see Data S1). The relatively smooth
curve of @U/@l (U, potential energy) indicates a converged
result for the electrostatic interacting energy. Next, starting
from the proceeding system with a l-value of zero, in which
there is no electrostatic interaction between ligand and envi-
ronment, we then slowly reduced the van der Waals (VDW)
energy to zero. For the TI method, the treatment of the VDW
potential energy is not a trivial issue, especially when the
interaction between ligand and potential is not strong enough
to ‘‘hold’’ the ligand in the binding pocket. Here we used a
soft-core potential to smooth the nonbonded potential energy
terms if two particles approached too closely (7). Moreover,
we carried out additional simulations with different l-values
to obtain a smooth @U/@l curve. We did not introduce
restraints to artificially hold the ligand in the binding pocket as
discussed in previous studies (8–10). However, we aremainly
interested in the relative free energy difference between two
similar ligands and the correction term related to the double-
decoupling method without restraints should not introduce a
significant error. The well-behaved @U/@l curves for both
cAMP and cGMP suggest amore-or-less converged sampling
(Fig. 1).
The final TI results show that the binding free energy of
cAMP is 51.9 kJ/mol more negative than that of cGMP
(Table 2). Even though this value is higher than the estimates
based on experimental data (;10 kJ/mol), the direction of
change is consistent: cAMP has a lower (more favorable)
binding free energy than cGMP. More importantly, this
calculation revealed that the major contribution to the differ-
ence between cAMP and cGMP is not the interaction between
protein and ligand (DGpro), but the solvation energy (DGH2O,
which equals 507.2 kJ/mol for cAMP versus 762.5 for
cGMP). Thus, these simulation results provide a simple answer
for the question as to why the HCN channel selects cAMP:
there is a higher penalty for cGMP to dehydrate.
Next we used an alternative approach, linear interaction
energy (LIE), which is an endpoint approach that has less
computational cost compared to the TI method. After ad-
justing the parameters for the LIE method based on exper-
imental measurements (see Data S1), we calculated the
absolute binding free energies of cAMPor cGMP for thewild-
type HCN2 CNBD. Similar to the TI results, we were mainly
interested in the difference between the binding energy of
cAMP and cGMP, but not the absolute binding energy. A
similar result was seen regarding the free energy difference
between the two ligands: cAMP has a more favorable binding
energy than cGMP due to the higher solvation energy of
cGMP. Furthermore, ensemble-averaged potential energies
revealed that this is mainly due to a stronger electrostatic
TABLE 1 Binding free energy estimates based on
physiological experiments
Six-state model
Ko (mM) Kc (mM)
cAMP 12.0 0.4
cGMP 1.2 9.9
DDG (kJ/mol) 13.2 10.32
FIGURE 1 Original @U/@l data in the TI analysis are plotted as a
function ofl. (Left) cAMP (black) or cGMP (red) free inwater; (right)
cAMP or cGMP bound to protein. (Solid circles) Electrostatic
potential energy (COUL); (open circles) VDW energy (VDW).
TABLE 2 Binding free energies by TI (kJ/mol)
cAMP cGMP
H2O Protein 1 H2O H2O Protein 1 H2O
DGCOUL 499.8 2089.6 754.9 3089.4
DGVDW 7.4 338.1 7.6 307.6
DGCOUL 1 DGVDW 507.2 2427.7 762.5 3397.0
DGbinding ¼
4 3 DGH2O  DGPro
398.9 347.0
DDG ¼
DGcAMP  DGcGMP
51.9
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interaction between cGMP and water. The final results of
LIE are shown in Table 3.
Finally, as a further theoretical approach to assessing the
mechanism of cNMP selectivity, we used continuum elec-
trostatic calculations (DELPHI and APBS) to estimate the
polar solvation energy of both ligands (11–13). Disadvan-
tages of this method include the need for two arbitrarily
defined dielectric constants and ignorance of ligand flexibility
due to rotation around the dihedral bond between the purine
ring and sugar base. Here we used the conformation of cAMP
and cGMP in the crystal structures and the partial charges and
VDW radii settings from GROMACS. APBS results showed
that the polar or electrostatic part of the solvation energy
corresponding to the transfer of a ligand from a homogenous
medium of dielectric constant 2 (protein) to a medium of
dielectric constant 78 (water) is 437.2kJ/mol for cAMP
(anti) versus 486.9 kJ/mol for cGMP (syn), representing a
49.7 kJ/mol more favorable energy of hydration for cGMP.
An independent calculation using DELPHI showed that the
polar part of the solvation energy (corrected reaction field
energy) of cGMP is 45.2 kJ/mol more favorable compared
to cAMP, in good agreement with the APBS results. The dif-
ference in the nonpolar solvation energy could be estimated
from the solvent-accessible surface area.We ignored this term
in the current study because the surface areas are within 3% of
each other.Moreover, considerable uncertainty exists as to the
proper value for the nonpolar energy coefficient.
In summary, we used three different theoretical methods to
estimate the free energy of binding of cAMP and cGMP to
the HCN2 CNBD. These different approaches differ in their
complexity, from the rigorous but computationally costly
pathway method (TI), to a less complex endpoint method
(LIE), to continuum electrostatics. All of the approaches
yielded results in good qualitative agreement with the phys-
iological characterization of the wild-type and mutant chan-
nels, thereby providing a potential mechanistic explanation
for the selectivity of HCN channels for cAMP relative to
cGMP. Surprisingly, we find that the major contribution to
the selectivity of the channel for cAMP is due to the higher
energetic penalty of desolvation of cGMP compared to
cAMP, rather than due to specific interactions of cAMP with
the protein. Such results help explain the failure so far to
identify experimentally specific CNBD residues that selec-
tively stabilize cAMP versus cGMP. These results are likely
to help explain cAMP selectivity in a variety of CNBDs.
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TABLE 3 Binding free energies using LIE (kJ/mol)
cAMP cGMP
H2O Protein 1 H2O H2O Protein 1 H2O
a 3 (VCOUL) 328.6 1153.9 344.1 1182.9
b 3 (VVDW) 15.4 148.1 14.8 145.2
a 3 (VCOUL)1
b 3 (VVDW)
344.1 1302.0 358.9 1328.1
Surface area (A˚2) 401 (anti) 408 (syn)
DGbinding* ¼
4 3 DGH2O  DGPro
74.4 107.5
DDG ¼
DGcAMP  DGcGMP
33.1
*Note that the third component in the method of LIE related to the surface
area is omitted due to the similar chemical structure of cAMP and cGMP
and a lack of referenceable parameter for the cNMP system.
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